AW, H., & AM, M. (2017). Obiltoxaximab: Adding to the Treatment Arsenal for Bacillus anthracis Infection. The Annals of pharmacotherapy, 51(10), 908. https://doi.org/10.1177/1060028017713029
Chicago Style (17th ed.) CitationAW, Hou, and Morrill AM. "Obiltoxaximab: Adding to the Treatment Arsenal for Bacillus Anthracis Infection." The Annals of Pharmacotherapy 51, no. 10 (2017): 908. https://doi.org/10.1177/1060028017713029.
MLA (9th ed.) CitationAW, Hou, and Morrill AM. "Obiltoxaximab: Adding to the Treatment Arsenal for Bacillus Anthracis Infection." The Annals of Pharmacotherapy, vol. 51, no. 10, 2017, p. 908, https://doi.org/10.1177/1060028017713029.
Warning: These citations may not always be 100% accurate.